LCC Technologies

LCC Technologies is a drug discovery company providing biopharma partners with access to its platform, which combines a proprietary billion-scale virtual chiral library with AI-driven design and automated high-throughput synthesis.

The platform delivers stereodefined, sp3-rich building blocks and drug-like compounds across target classes including kinases, GPCRs, and deubiquitinases.

LCC operates as the UK arm of XtalPi, a global AI and robotics-driven R&D platform.